[SVNS] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[SVNS] Solvonis Therapeutics plc
Announcement Date
30-Dec-2023
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -15.34%
Quarter Report
SVNS's Result
SVNS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/05/21 31/05/20 31/05/19 31/05/18 CAGR
Revenue 587 542 219 691 330 29 0 -
PBT -3,120 -2,705 -954 -274 -538 -703 -494 39.06%
Tax 0 0 0 -0 -58 -92 -8 -
NP -3,120 -2,705 -954 -274 -538 -703 -494 39.06%
Tax Rate - - - - - - - -
Total Cost 3,707 3,247 1,173 965 868 732 494 43.41%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/05/21 31/05/20 31/05/19 31/05/18 CAGR
NP Margin -531.52 -499.08 -435.62 -39.70 -163.03 -2,424.14 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/05/21 31/05/20 31/05/19 31/05/18 CAGR
EPS -0.03 -0.03 -0.01 -0.00 -0.01 -0.01 -0.00 -
EPS Diluted -0.03 -0.03 -0.01 -0.00 -0.01 -0.01 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.